Trial intelligence / Profile preview

Na-GST-1 Vaccine with/without CPG 10104 in Gabonese Adults

NCT03373214Phase 1Completed

Sponsor
Baylor College of Medicine
Start
Feb 2018
Primary completion
Feb 2019
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of Necator americanus Glutathione-S-Transferase-1 in hookworm infection (3 arms), sponsored by Baylor College of Medicine. Primary endpoint: Vaccine-related Adverse Events at Day 380. Started Feb 2018; status: completed.

02

Drugs

Necator americanus Glutathione-S-Transferase-1
03

Conditions

hookworm infection

Beyond the preview

Go deeper on NCT03373214.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03373214.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call